Skip to main content
Premium Trial:

Request an Annual Quote

Caris Life Sciences Gets ISO 15189 Accreditation for Lab

NEW YORK (GenomeWeb News) – Caris Life Sciences today said that its tumor profiling lab in Phoenix, Ariz., has received ISO 15189 accreditation.

The accreditation was provided by the American Association for Laboratory Accreditation. The ISO 15189 standard covers qualifications and ongoing competency of the company's laboratory personnel, laboratory accommodation, equipment, reagents and supplies, pre-analytical and analytical factors, quality assurance considerations, and post-analytical factors, said Irving, Texas-based Caris.

The lab performs genomic testing associated with Caris Molecular Intelligence, the firm's tumor profiling service, which provides therapeutic guidance for up to 43 drug associations, "far exceeding the 12 that can be identified using next-generation sequencing alone," the firm said in a statement.

In addition to the ISO 15189 accreditation, the firm's lab also has a CLIA license, licenses from individual states including New York, and its biorepository has earned College of American Pathologists accreditation.